CL 283,546

acyl conenzyme A:cholesterol acyltransferase inhibitor; structure given in first source

Also Known As:

CL-283546; N'-heptyl-N-((4-(3-methylbutyl)phenyl)methyl)-N'-(2,4,6-trifluorophenyl)urea

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Atherosclerosis 06/01/1995 - "This study was conducted to examine the effects of two ACAT inhibitors, CL 283,546 and CL 283,796, in cholesterol-high fat diet fed African green monkeys, a relevant primate model of hyperlipidemia and coronary artery atherosclerosis. "
2.	Hyperlipidemias (Hyperlipidemia) 06/01/1995 - "This study was conducted to examine the effects of two ACAT inhibitors, CL 283,546 and CL 283,796, in cholesterol-high fat diet fed African green monkeys, a relevant primate model of hyperlipidemia and coronary artery atherosclerosis. "